Nabi Biopharmaceuticals Initiates Pivotal Phase III Study for NicVAX as an Aid to Smoking Cessation and Long-term Abstinence
November 03, 2009 09:15 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Nov. 3, 2009 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced that it has initiated the first of two pivotal Phase III clinical trials for NicVAX(R) (Nicotine...
Nabi Biopharmaceuticals Participates in NicVAX(R) Phase IIb Study
October 28, 2009 09:00 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Oct. 28, 2009 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced that it is participating in an investigator initiated Phase IIb study to evaluate the safety and...
Nabi Biopharmaceuticals to Announce Third Quarter Financial Results on November 5, 2009
October 27, 2009 10:30 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Oct. 27, 2009 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that it will report its third quarter 2009 financial results on Thursday, November 5, 2009,...
Nabi Biopharmaceuticals Receives Grant Supporting Further NicVAX Development
September 29, 2009 11:00 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Sept. 29, 2009 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) and the U.S. National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, announced...
Nabi Biopharmaceuticals to Present At Rodman & Renshaw's Annual Global Investment Conference
September 01, 2009 16:00 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Sept. 1, 2009 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that Dr. Raafat Fahim, President and Chief Executive Officer will present at the Rodman &...
Nabi Biopharmaceuticals Announces Second Quarter 2009 Financial Results
August 06, 2009 16:05 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Aug. 6, 2009 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced its second quarter financial results for the three month period ended June 27, 2009. The Company...
Nabi Biopharmaceuticals Announces Sale of PentaStaph(tm) to GlaxoSmithKline PLC
August 06, 2009 16:00 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Aug. 6, 2009 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced that it has signed a definitive agreement for the sale of PentaStaph(tm) (Pentavalent S. aureus...
Nabi Biopharmaceuticals to Announce 2009 Second Quarter Financial Results on August 6, 2009
July 28, 2009 10:00 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., July 28, 2009 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that it will report its 2009 second quarter financial results on Thursday, August 6, 2009, after...
Nabi Biopharmaceuticals Receives Scientific Advice On NicVAX(r) From the European Medicines Agency
June 03, 2009 08:00 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., June 3, 2009 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced it has received scientific advice from the European Medicines Agency (EMEA) on NicVAX regarding the...
Nabi Biopharmaceuticals to Present At Noble Financial's Fifth Annual Equity Conference
June 02, 2009 10:30 ET
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., June 2, 2009 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that Dr. Raafat Fahim, President and Chief Executive Officer, will present at Noble Financial...